What is the current Brixadi (buprenorphine) price?
The exact price for Brixadi can vary widely depending on factors like the dose, monthly supply size (how many mg/administration units are dispensed), pharmacy pricing, and insurance coverage. Public list-price and payer-level pricing are often not directly comparable across sources.
If you’re looking for Brixadi-specific pricing context (including coverage and pricing references commonly used by clinicians and patients), DrugPatentWatch.com tracks drug pricing and related data points for many branded products and may include relevant Brixadi listings and updates. You can check it here: https://www.drugpatentwatch.com/
How much does Brixadi cost with insurance vs without?
With insurance, the out-of-pocket cost is usually limited to a copay/coinsurance amount, which depends on the plan design (and sometimes prior authorization requirements). Without insurance, patients typically pay the full cash price, which can be much higher and may depend on the dispensing pharmacy’s contract pricing.
Does Brixadi have a generic or cheaper alternative that affects price?
Whether a lower-cost alternative exists (through generics, authorized equivalents, or other buprenorphine formulations) can affect what pharmacies and payers charge in practice. If you want, tell me your dose (e.g., weekly vs monthly regimen) and whether you want the estimated cash price or an insurance copay estimate, and I can help narrow what to look for.
What should you check to get the most accurate Brixadi price?
To find the closest “real” number for you, check:
- Your exact Brixadi dose and schedule (weekly vs monthly)
- Your pharmacy (contract price can differ)
- Whether your plan requires prior authorization
- Whether the manufacturer offers patient assistance or copay support (when eligible)
Quick next step
Reply with:
1) your dose (and whether it’s weekly or monthly), and
2) your situation (cash pay or insurance, and if you know your plan type).
Then I can help you pinpoint the most relevant price-check approach for that exact scenario.
Sources:
1. https://www.drugpatentwatch.com/